BioSpace News Archive

Healthy.io Raises $60 Million in Series C Funding and Receives FDA Clearance for Smartphone-Based Test to Diagnose Chronic Kidney Disease

Former Aetna executive Gary Loveman will join Board of Directors

September 12, 2019
·
5 min read
snapIoT Appoints Industry Veterans Charlie Mains and Christian Knaus To Their Leadership Team

September 12, 2019
·
2 min read
Deals

Inotrem Announces €39 Million Series B Financing to Develop First-In-Class Immunology Therapeutics

Inotrem S.A. announced a €39 million Series B financing led by Morningside Ventures, joined by Invus with participation from existing investors Andera Partners, Sofinnova Partners and BiomedInvest.

September 12, 2019
·
4 min read
Business

Endospan Enters Into Strategic Distribution Agreement With CryoLife

CryoLife acquires exclusive European distribution rights to the NEXUS™ Stent Graft System, the first endovascular off-the-shelf stent graft system indicated for treatment of aortic arch disease.

September 12, 2019
·
2 min read
Canada leading developed countries in survival for lung and colon cancer

New data shows where Canada ranks internationally in survival for seven types of cancer

September 12, 2019
·
5 min read
Deals

Vision Innovation Partners (formerly Chesapeake Eye Care) Acquires Washington, D.C. Practice, Continuing Aggressive Mid-Atlantic Growth

Vision Innovation Partners is pleased to announce its acquisition of Washington Eye Specialists, a leading ophthalmology practice located in Washington, D.C. The acquisition further expands Vision Innovation Partners’ growing network of ophthalmology practices in the Mid-Atlantic region.

September 12, 2019
·
2 min read
Drug Development

Medicenna to Present Latest Data from the MDNA55 Clinical Trial in Recurrent Glioblastoma at the Targeting Innate Immunity Congress

Medicenna Therapeutics Corp. announced that it will present updated clinical results from the Phase 2b clinical trial of MDNA55 for the treatment of recurrent glioblastoma at the Inaugural Targeting Innate Immunity Congress to be held on September 24 and 25, 2019 in Cambridge, MA.

September 12, 2019
·
3 min read
Business

Bristol-Myers Squibb to Announce Results for Third Quarter 2019 on October 31, 2019

Bristol-Myers Squibb Company will announce results for the third quarter of 2019 on Thursday, October 31, 2019.

September 12, 2019
·
1 min read
Drug Development

Concert Pharmaceuticals Announces CTP-543 Phase 2 Alopecia Areata Data Selected for Late-Breaker Oral Presentation at 2019 EADV Congress

Concert Pharmaceuticals, Inc. announced that it will present results from its recently completed Phase 2 trial of CTP-543 in patients with moderate-to-severe alopecia areata.

September 12, 2019
·
4 min read
Job Trends

Health Catalyst Shares Insights From Annual Healthcare Analytics Summit

Discussion focused on powering digital transformation in healthcare

September 12, 2019
·
2 min read